Discovery of a New Drug - From Target Identification to Ultra-High-Throughput Screening
Golz, S.; Jörg Hüser
Clinical Laboratory 53(1-2): 77-79
2007
ISSN/ISBN: 1433-6510 PMID: 17323829 Document Number: 8726
Document emailed within 1 workday
Related Documents
Chang, G.; Ruggeri, R.B.; Harwood, H.James. 2002: Microsomal triglyceride transfer protein (MTP) inhibitors: discovery of clinically active inhibitors using high-throughput screening and parallel synthesis paradigms Current Opinion in Drug Discovery and Development 5(4): 562-570Mohamed, T.M.A.; Zakeri, S.A.; Baudoin, F.; Wolf, M.; Oceandy, D.; Cartwright, E.J.; Gul, S.; Neyses, L. 2013: Optimisation and validation of a high throughput screening compatible assay to identify inhibitors of the plasma membrane calcium ATPase pump--a novel therapeutic target for contraception and malaria Journal of Pharmacy and Pharmaceutical Sciences: a Publication of the Canadian Society for Pharmaceutical Sciences Societe Canadienne des Sciences Pharmaceutiques 16(2): 217-230
Zhao, S.-S.; Wang, J.-X.; Wang, Y.-C.; Shao, R.-G.; He, H.-W. 2015: Establishment and application of a high-throughput drug screening model based on COL1A1 promoter for anti-liver fibrosis Yao Xue Xue Bao 50(2): 169-173
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Leung, Y.F.; Tam, P.O.; Tong, W.C.; Baum, L.; Choy, K.W.; Lam, D.S.; Pang, C.P. 2001: High-throughput conformation-sensitive gel electrophoresis for discovery of SNPs Biotechniques 30(2): 334-5 338-40
Seifert, M.H.J.; Kraus, J.ür.; Kramer, B. 2007: Virtual high-throughput screening of molecular databases Current Opinion in Drug Discovery and Development 10(3): 298-307
Ren, D-cheng.; Du, G-hua.; Zhang, J-tian. 2003: High throughput screening for intercellular adhesion molecule-1 inhibitor Yao Xue Xue Bao 38(6): 405-408
Pan, Y-ping.; Xu, X-hua.; Wang, X-liang. 2004: High throughput screening method of potassium channel regulators Yao Xue Xue Bao 39(2): 85-88
Płocinska, R.; Korycka-Machala, M.; Plocinski, P.; Dziadek, J. 2017: Mycobacterial DNA Replication as a Target for Antituberculosis Drug Discovery Current Topics in Medicinal Chemistry 17(19): 2129-2142
Imaizumi, Y.; Kaneko, S. 2011: Study on ion channel transporters as a target for the drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 138(6): 227
Lowe, J.A.; Jones, P.; Wilson, D.M. 2009: The importance of target validation in drug discovery and development Current Opinion in Drug Discovery and Development 12(5): 581-584
Sun, W-Zen. 2006: Translational medicine in ultra-long injectable opioid drug discovery--when abuse liability and toxicity meet analgesic efficacy Acta Anaesthesiologica Taiwanica: Official Journal of the Taiwan Society of Anesthesiologists 44(3): 133-134
Haramura, M. 2007: Application of chemical biology to proteomics in drug target discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 129(2): 124-128
Lavery, K.S.; King, T.H. 2003: Antisense and RNAi: powerful tools in drug target discovery and validation Current Opinion in Drug Discovery and Development 6(4): 561-569
Stefan, P.; Moritz, E.; Alexander, W.; Matthias, W. M.; Norbert, D.; Annette, W.; Thomas, F.; Pfützner Andreas 2009: Development of a High-Throughput Method for Screening the Dopamine D2 (DRD2) Receptor Gene Polymorphisms Based on the LightCycler® System Clinical Laboratory 55(9-10): 353-358
Garvey, R. 2006: Target specific seminars in drug discovery--IBC conference. 24-26 April 2006, Berlin, Germany IDrugs: the investigational drugs journal 9(7): 474-475
Shao, C.; Xu, S.; Song, Y.; Zhu, D. 2017: Screening of antitumor polypeptide drug and enhanced CT imaging based on drug target analysis Pakistan Journal of Pharmaceutical Sciences 30(5(Special): 1883-1888
Savino, M.; Seripa, D.; Gallo, A.P.; Garrubba, M.; Grazia D’Onofrio; Bizzarro, A.; Paroni, G.; Paris, F.; Mecocci, P.; Masullo, C.; Pilotto, A.; Santini, S.A. 2011: Effectiveness of a High-Throughput Genetic Analysis in the Identification of Responders/Non-responders to CYP2D6-Metabolized Drugs Clinical Laboratory 57(11-12): 887-893
Liu, X.; Li, H.; Bi, K.-S.; Chen, X.-H.; Cai, H.; Cai, B.-C. 2012: Identification of metabolites of arbidol by ultra-high performance liquid chromatography tandem mass spectrometry Yao Xue Xue Bao 47(11): 1521-1526
Zartler, E.R.; Shapiro, M.J. 2006: Protein NMR-based screening in drug discovery Current Pharmaceutical Design 12(31): 3963-3972